Last week a literature review showed none of 62 high-quality medical AI models ready for translation from academic research to clinical practice. Now comes a similar but separate study confirming the depth of the dashed hopes.

An AI system for diagnosing prostate cancer on biopsy slides has achieved 98%-plus performance in sensitivity, positive predictive value, specificity and negative predictive value.

An established company in the spinal device market has added a 3D-printed vertebral spacer to its line of FDA-cleared products.

The FDA has given the all-clear to AI software that measures nodules in the lungs, a tedious but important task for radiologists monitoring changes in these growths over time.

Apart from software, the technique needs nothing more than a halogen lamp and a commercial-grade spectrometer. This pairing can be had together for well under $5,000.

Of five emerging technologies used by nurses to help control infectious diseases, the Internet of Things is the most promising, researchers have concluded. 

The FDA has granted 510(k) clearance to clinical decision support software that uses AI to detect small but potentially cancerous lesions in the lungs.

The FDA has blessed an AI-packing armband that checks for biometric patterns pointing to possible SARS-CoV-2 infection in individuals with no symptoms.

Two healthcare heavyweights are combining forces to form a technology center they hope will, over the next 10 years, “fundamentally advance the pace” of discovery in medical science and healthcare innovation.

A major collegiate athletic conference is teaming with a top-tier academic healthcare system and a popular fitness technology company to study the utility of wearables for preventing or monitoring infectious diseases in student-athletes.